Real-World Analysis of Breast Cancer Patients Qualifying for Adjuvant CDK4/6 Inhibitors. Kanjanapan Y, Anderson W, Smith M, Green J, et al. Clin Breast Cancer 2024 Aug 29:S1526-8209(24)00234.

Read + Share

Amedeo Smart

Independent Medical Education

Kanjanapan Y, Anderson W, Smith M, Green J, et al. Real-World Analysis of Breast Cancer Patients Qualifying for Adjuvant CDK4/6 Inhibitors. Clin Breast Cancer 2024 Aug 29:S1526-8209(24)00234.
PMID: 39294027